Skip to main content
SpringerLink
Log in

Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data

  • Daunorubicin-DNA and Doxorubicin-DNA
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Experimental data on the pharmacokinetic, toxic and therapeutic properties of daunorubicin-DNA and doxorubicin-DNA complexes are reviewed and summarized as well as the available reports on clinical trials performed with these anthracycline-DNA complexes.

These results are discussed in view of the further development of the drug-carrier concept of cancer chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Atassi, G., Tagnon, H. J., Trouet, A.: Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L 1210 leukemia. Eur. J. Cancer 10, 399 (1974)

    Google Scholar 

  2. Barlogie, B., Drewinko, B., Benjamin, R. S., Freireich, E. J.: Kinetic response of human lymphoid cells to adriamycin-DNA complex in vitro. Cancer Res. 36, 2450 (1976)

    Google Scholar 

  3. Baurain, R., Deprez-De Campeneere, D., Trouet, A.: Distribution and metabolism of rubidazone and daunorubicin in mice: A comparative study. Cancer Chemother. Pharmacol. 2, 37–41 (1979)

    Google Scholar 

  4. Beran, M., Andersson, B., Eksborg, S., Ehrsson, H.: Comparative studies on in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol and daunorubicin-DNA complex. Cancer Chemother. Pharmacol. 2, 19–24 (1979)

    Google Scholar 

  5. Bosly, A., Prignot, J., Ledent, C., Sokal, G., Trouet, A.: Adriamycin and adriamycin-DNA in inoperable bronchogenic carcinoma. A randomized study with cyclophosphamide vinblastine. Eur. J. Cancer 14, 639 (1978)

    Google Scholar 

  6. Brown, I., Ward, H. W. C.: The comparative toxicity and therapeutic efficacy of adriamycin and the adriamycin-DNA complex in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma. Cancer Lett. 2, 227 (1977)

    Google Scholar 

  7. Cornu, G., Michaux, J. L., Sokal, G., Trouet, A.: Daunorubicin-DNA: Further clinical trials in acute non-lymphoblastic leukemia. Eur. J. Cancer 10, 695 (1974)

    Google Scholar 

  8. Deckers, C., Mace, F., Deckers-Passau, L., Trouet, A.: Antitumor effect of adriamycin and adriamycin-DNA complex in rat immunocytoma and leukemia. In: Adriamycin review. Staquet, M. et al. (eds.), p. 79, Ghent, Belgium: European Press Medikon 1975

    Google Scholar 

  9. Deprez-De Campeneere, D., Baurain, R., Huybrechts, M., Trouet, A.: Comparative study in mice of the toxicity, pharmacology and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes. Cancer Chemother. Pharmacol. 2, 25–30 (1979)

    Google Scholar 

  10. Ferrant, A., Hulhoven, R., Bosly, A., Cornu, G., Michaux, J. L., Sokal, G.: Clinical trials with daunorubicin-DNA and doxorubicin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia and bronchogenic carcinoma. Cancer Chemother. Pharmacol. 2, 67–71 (1979)

    Google Scholar 

  11. Langslet, A., Øye, I., Lie, S. O.: Decreased cardiac toxicity of adriamycin and daunorubicin when bound to DNA. Acta Pharmacol. Toxicol. (Kbh.) 35, 379 (1974)

    Google Scholar 

  12. Langslet, A., Øye, I., Lie, S. O.: Reduction of the immediate cardiac toxicity of adriamycin and daunorubicin when bound to DNA. In: Adriamycin review. Staquet, M. et al. (eds.), p. 143. Ghent, Belgium: European Press Medikon 1975

    Google Scholar 

  13. Lie, S. O., Lie, K. K., Langslet, A.: Experiences with DNA-adriamycin complex in malignant disorders of childhood. In: Adriamycin review. Staquet, M. et al. (eds.), p. 226. Ghent, Belgium: European Press Medikon 1975

    Google Scholar 

  14. Lie, S. O., Lie, K. K., Glomstein, A.: Adriamycin-DNA complex: A new principle in the therapy of childhood malignancies (Meet. Abstr.). Pediatr. Res. 11, 1019 (1977)

    Google Scholar 

  15. Lie, S. O., Lie, K. K., Glomstein, A.: Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease. Cancer Chemother. Pharmacol. 2, 61–66 (1979)

    Google Scholar 

  16. Longueville, J., Maisin, H.: Combined therapy with adriamycin-DNA, vincristine and medroxy-progesterone acetate in metastatic breast cancer. In: Adriamycin review. Staquet, M. et al. (eds.), p. 260. Ghent, Belgium: European Press Medikon 1975

    Google Scholar 

  17. Michaux, J. L., Cornu, G., Trouet, A., Sokal, G.: Clinical trials with the daunorubicin-DNA complex in human leukaemia. A preliminary report. In: Therapy of acute leukemias, p. 815. Proc. Int. Meet., Rome, December 6–8, 1973

  18. Michaux, J. L., Cornu, G., Sokal, G., Trouet, A.: Preliminary clinical trials with the adriamycin-DNA complex in human leukemias and non-Hodgkin lymphomas. In: Adriamycin review. Staquet, M. et al. (eds.), p. 216, Ghent, Belgium: European Press Medikon 1975

    Google Scholar 

  19. Peterson, C., Noel, G., Zenebergh, A., Trouet, A.: Uptake of daunorubicin-DNA complex in cultured fibroblasts. Cancer Chemother. Pharmacol. 2, 3–6 (1979)

    Google Scholar 

  20. Schneider, Y.-J., Baurain, R., Zenebergh, A., Trouet, A.: DNA binding of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro. Cancer Chemother. Pharmacol. 2, 7–10 (1979)

    Google Scholar 

  21. Seeber, S., Brucksch, K. P., Seeber, B., Schmidt, C. G.: Cytostatic efficacy of DNA complexes of adriamycin, daunomycin and actinomycin D. I. Comparative studies in Novikoff hepatoma, human mammary carcinoma cells and human leukemic leukocytes. Krebsforsch. Klin. Onkol. 89, 75 (1977)

    Google Scholar 

  22. Sokal, G., Trouet, A., Michaux, J. L., Cornu, G.: DNA-daunorubicin complex: Preliminary trials in human leukaemia. Eur. J. Cancer 9, 391 (1973)

    Google Scholar 

  23. Trouet, A.: Increased selectivity of drugs by linking to carriers. Eur. J. Cancer 14, 105 (1978)

    Google Scholar 

  24. Trouet, A., Deprez-De Campeneere, D., de Duve, C.: Chemotherapy through lysosomes with a DNA-daunorubicin complex. Nature [New Biol.] 239, 110 (1972)

    Google Scholar 

  25. Trouet, A., Deprez-De Campeneere, D., De Smedt-Malengreaux, M., Atassi, G.: Experimental leukemia chemotherapy with a ‘lysosomotropic’ adriamycin-DNA complex. Eur. J. Cancer 10, 405 (1974)

    Google Scholar 

  26. Trouet, A., Deprez-De Campeneere, D., Baurain, R., Huybrechts, M., Zenebergh, A.: Desoxyribonucleic acid as carrier for antitumoral drugs. In: Carriers in biology and medicine. Gregoriadis, G. (ed.). (in press, 1978)

Download references

Author information

Authors and Affiliations

  1. International Institute of Cellular and Molecular Pathology, 75, avenue Hippocrate, Brussels, Belgium

    A. Trouet & D. Deprez-De Campeneere

  2. Université de Louvain, 75, avenue Hippocrate, Brussels, Belgium

    A. Trouet & D. Deprez-De Campeneere

Authors
  1. A. Trouet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Deprez-De Campeneere
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trouet, A., Deprez-De Campeneere, D. Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data. Cancer Chemother. Pharmacol. 2, 77–79 (1979). https://doi.org/10.1007/BF00253110

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00253110

Keywords

Search

Navigation